HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitochondrial oxidative phosphorylation in autosomal dominant optic atrophy.

AbstractBACKGROUND:
Autosomal dominant optic atrophy (ADOA), a form of progressive bilateral blindness due to loss of retinal ganglion cells and optic nerve deterioration, arises predominantly from mutations in the nuclear gene for the mitochondrial GTPase, OPA1. OPA1 localizes to mitochondrial cristae in the inner membrane where electron transport chain complexes are enriched. While OPA1 has been characterized for its role in mitochondrial cristae structure and organelle fusion, possible effects of OPA1 on mitochondrial function have not been determined.
RESULTS:
Mitochondria from six ADOA patients bearing OPA1 mutations and ten ADOA patients with unidentified gene mutations were studied for respiratory capacity and electron transport complex function. Results suggest that the nuclear DNA mutations that give rise to ADOA in our patient population do not alter mitochondrial electron transport.
CONCLUSION:
We conclude that the pathophysiology of ADOA likely stems from the role of OPA1 in mitochondrial structure or fusion and not from OPA1 support of oxidative phosphorylation.
AuthorsVladimir I Mayorov, Angela J Lowrey, Valerie Biousse, Nancy J Newman, Susan D Cline, Michael D Brown
JournalBMC biochemistry (BMC Biochem) Vol. 9 Pg. 22 (Sep 10 2008) ISSN: 1471-2091 [Electronic] England
PMID18783614 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • GTP Phosphohydrolases
  • OPA1 protein, human
Topics
  • Electron Transport (genetics)
  • GTP Phosphohydrolases (genetics, metabolism)
  • Humans
  • Mitochondria (metabolism)
  • Mutation
  • Optic Atrophy, Autosomal Dominant (genetics, metabolism)
  • Oxidative Phosphorylation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: